Medicare Enrolled
Dr. Steven Geller, DO
Pulmonary Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Geller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Geller
Dr. Steven Geller is a pulmonary disease specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Geller performed 1,172 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Geller received a total of $242,468 from 53 pharmaceutical and/or device companies across 1255 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Geller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 24% volume in PA
$242,468 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,172
Medicare services
Top 24% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
485 | $95 | $275 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
326 | $63 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $63 | $190 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $117 | $350 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
61 | $98 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
52 | $105 | $245 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $142 | $360 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
19 | $33 | $120 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
17 | $13 | $125 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
16 | $24 | $120 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $63 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$242,468
Total received (2018-2024)
Avg $34,638/year across 7 years
Top 2% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,255
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$63,464
2023
$68,326
2022
$45,075
2021
$35,190
2020
$16,675
2019
$3,787
2018
$9,950
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$36,342
GlaxoSmithKline, LLC.
$24,400
Regeneron Healthcare Solutions, Inc.
$466
JAZZ PHARMACEUTICALS INC.
$360
GENZYME CORPORATION
$291
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
HARMONY BIOSCIENCES LLC
$203
Electromed, Inc.
$172
Actelion Pharmaceuticals US, Inc.
$162
Amgen Inc.
$123
Inspire Medical Systems, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$71
Philips North America LLC
$69
Mallinckrodt Hospital Products Inc.
$63
ANI Pharmaceuticals, Inc.
$58
Axsome Therapeutics, Inc.
$57
Insmed, Inc.
$47
Genentech USA, Inc.
$43
Baxter Healthcare
$35
United Therapeutics Corporation
$20
Optinose US, Inc.
$20
Mylan Specialty L.P.
$20
Myriad Genetic Laboratories, Inc.
$18
Pulmonx Corporation
$17
PFIZER INC.
$17
La Jolla Pharmaceutical Company
$16
WATERMARK MEDICAL, INC.
$14
Top 3 companies account for 96.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$136,800
AstraZeneca Pharmaceuticals LP
$87,017
Amgen Inc.
$4,279
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,644
Regeneron Healthcare Solutions, Inc.
$1,613
United Therapeutics Corporation
$1,347
Mylan Specialty L.P.
$1,141
Actelion Pharmaceuticals US, Inc.
$1,036
GENZYME CORPORATION
$984
JAZZ PHARMACEUTICALS INC.
$615
Insmed, Inc.
$586
Takeda Pharmaceuticals U.S.A., Inc.
$537
Philips Electronics North America Corporation
$529
Genentech USA, Inc.
$453
HARMONY BIOSCIENCES LLC
$415
Electromed, Inc.
$393
Grifols USA, LLC
$384
Advanced Respiratory, Inc
$306
Baxter Healthcare
$253
Mallinckrodt Hospital Products Inc.
$211
Shire North American Group Inc
$182
Sunovion Pharmaceuticals Inc.
$169
Merck Sharp & Dohme Corporation
$156
Mallinckrodt Enterprises LLC
$119
Teva Pharmaceuticals USA, Inc.
$111
ANI Pharmaceuticals, Inc.
$103
Inspire Medical Systems, Inc.
$101
Janssen Pharmaceuticals, Inc
$101
Novartis Pharmaceuticals Corporation
$95
Axsome Therapeutics, Inc.
$91
Harmony Biosciences LLC
$87
Philips North America LLC
$69
Jazz Pharmaceuticals Inc.
$69
Mallinckrodt LLC
$58
Merck Sharp & Dohme LLC
$50
ADVANCED RESPIRATORY, INC
$43
PFIZER INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
Resmed Corp
$28
Cumberland Pharmaceuticals, Inc.
$23
Sumitomo Pharma America, Inc.
$20
Optinose US, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Myriad Genetic Laboratories, Inc.
$18
Pulmonx Corporation
$17
La Jolla Pharmaceutical Company
$16
SANOFI-AVENTIS U.S. LLC
$16
Circassia Pharmaceuticals Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
CSL Behring
$14
WATERMARK MEDICAL, INC.
$14
Shionogi Inc
$13
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
(2928) NIV other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADVAIR · AIRSENSE · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ARALAST · ARES 620 UNICORDER · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Fetroja · GEMTESA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · IMFINZI · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · LifeVest · Lunoa 1 0 · NONE · NUCALA · Nubeqa · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PROLARIS · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · REMODULIN · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vibativ · Volara System · WAKIX · Wakix · Wellcentive Undiv · XACDURO · XARELTO · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
271
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
JEFFERSON HEALTH- NORTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Geller is a clinical cardiology specialist, with above-average Medicare volume (top 24% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Geller experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Geller performed 485 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Geller receive payments from pharmaceutical companies?
Yes. Dr. Geller received a total of $242,468 from 53 companies across 1,255 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geller's costs compare to other pulmonary diseases in Philadelphia?
Dr. Geller's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Philadelphia
Browse pulmonary diseases in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology